Emisphere Technologies, Inc.   Report issue

For profit Phase 1
Founded: Roseland NJ United States (1986)
Status: Acquired by Novo Nordisk (2020)

Organization Overview

First Clinical Trial
2001
NCT00982254
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2008

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree